ITP
ONC

Iron Triangle Partners’s BeOne Medicines Ltd ONC Stock Holding History

Iron Triangle Partners’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-60,000
Closed -$14.5M – 37
2025
Q2 		$14.5M Sell
60,000
-37,840
-39% -$9.28M 2.23% 21
2025
Q1 		$26.6M Buy
+97,840
New +$22.9M 4.2% 10

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Iron Triangle Partners's ONC Position: Q3 2025 in Review

Iron Triangle Partners sold out of BeOne Medicines Ltd (ONC) in Q3 2025, closing a stake of 60,000 shares — an estimated $14.5M sold.

Iron Triangle Partners first reported a position in ONC in Q1 2025 and held it in 2 quarters. The position peaked at $26.6M in Q1 2025. 265 funds tracked by Wall St. Rank hold ONC as of Q3 2025.

  • Iron Triangle Partners reported no remaining BeOne Medicines Ltd position as of Q3 2025 after selling out during the quarter.
  • Iron Triangle Partners sold 60,000 BeOne Medicines Ltd shares in Q3 2025, an estimated $14.5M.
  • Iron Triangle Partners first reported a position in BeOne Medicines Ltd in Q1 2025 and held it in 2 quarters.
  • Iron Triangle Partners's BeOne Medicines Ltd position peaked at $26.6M in Q1 2025.
  • 265 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2025.

Based on Iron Triangle Partners's 13F filing for Q3 2025, filed 14 Nov 2025.